Clinical and Economic Impact of Long-Term Inhaled Corticosteroid Withdrawal in Patients with Chronic Obstructive Pulmonary Disease Treated with Triple Therapy in Spain
Victoria Neches García,1 Laura Amanda Vallejo-Aparicio,1 Afisi S Ismaila,2,3 Antoni Sicras-Mainar,4 Aram Sicras-Navarro,4 Cruz González,5 Rafael Cuervo,6 Soham Shukla,2 Marcos García-Peñuela6 1Market Access, GlaxoSmithKline, Madrid, Spain; 2Value Evidence and Outcomes, GlaxoSmithKline, Collegeville,...
Main Authors: | Neches García V, Vallejo-Aparicio LA, Ismaila AS, Sicras-Mainar A, Sicras-Navarro A, González C, Cuervo R, Shukla S, García-Peñuela M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-09-01
|
Series: | International Journal of COPD |
Subjects: | |
Online Access: | https://www.dovepress.com/clinical-and-economic-impact-of-long-term-inhaled-corticosteroid-withd-peer-reviewed-fulltext-article-COPD |
Similar Items
-
Pulmonologists’ Opinion on the Use of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease Patients in Spain: A Cross-Sectional Survey
by: Miravitlles M, et al.
Published: (2022-07-01) -
Lack of Association between Inhaled Corticosteroid Use and the Risk of Future Exacerbation in Patients with GOLD Group A Chronic Obstructive Pulmonary Disease
by: Sun Hye Shin, et al.
Published: (2022-05-01) -
Inhaled Corticosteroids and the Lung Microbiome in COPD
by: Holly R. Keir, et al.
Published: (2021-09-01) -
The Impact of Inhaled Corticosteroids on the Prognosis of Chronic Obstructive Pulmonary Disease
by: Park JW, et al.
Published: (2023-05-01) -
Inhaled Corticosteroid Use Among COPD Patients in Primary Care in Spain
by: Miravitlles M, et al.
Published: (2022-01-01)